RNF8 and breast cancer: To further support our hypothesis that miR-622 inhibited the expression of RNF8 in vitro, MDA-MB-231 breast cancer cells (a cell line with high expression of RNF8) (12) were transfected with the miR-622 agomir and antagomir, respectively.